Skip to main content
SpringerLink
Log in

Amide of Lambertian Acid Suppresses Hyperactivation of Inotropic Glutamate Receptors, but not Synaptic Potentiation in Hippocampal Sections

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Amide of lambertian acid suppresses hyperactivation of inotropic glutamate receptors in hippocampal sections induced by a decrease in the level of magnesium ions (a selective blocker of glutamate NMDA receptors). Treatment of the sections with amide of lambertian acid in standard physiological saline does not prevent development of NMDA-dependent synaptic potentiation. Lambertian acid isolated from needles and turpentine of Siberian pine (Pinus sibirica R. Mayr), and its derivatives may become a source of substances with glutamatergic mechanism of action for treatment of cognitive and neurodegenerative disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Nicholls JG, Martin AR, Wallace BG, Fuchs PA. From Neuron to Brain. Moscow, 2003. Russian.

  2. Popov SA, Kozlova LP, Shpatov AV, Shul’ts EE, Tolstikov GA. Patent RF No. 2436781. Method of Producing Lambertian Acid from Extracts of Green Siberian Cedar Wood. Byull. No. 35 (December 20, 2011).

  3. Tolstikova TG, Dolgikh MP, Tolstikov GA. Lambertian acid and its amino derivatives: a new group of perspective neurotropic agents. Dokl. Biol. Sci. 2000;374(1-6):445-447.

    CAS  PubMed  Google Scholar 

  4. Tolstikova TG, Sorokina IV, Dolgikh MP, Kharitonov YuV, Chernov SV, Shul’ts EE, Tolstikov GA. Search for new drugs: Neurotropic activity of lambertianic acid adducts with N-substituted maleinimides. Pharm. Chem. J. 2004;38(10):532-534.

  5. Anderson WW, Lewis DV, Swartzwelder HS, Wilson WA. Magnesium-free medium activates seizure-like events in rat hippocampal slice. Brain Res. 1986;398(1):215-219.

    Article  CAS  PubMed  Google Scholar 

  6. Danysz W, Parsons CG, Bresink I, Quack G. Glutamate in CNS disorders:a revived target for drug development? Drug News Perspec. 1995;8(5):261-277.

    Google Scholar 

  7. Dingledine R, Borges K, Bowie D, Traynelis SF. The glutamate receptor ion channels. Pharmacol. Rev. 1999;51(1):7-61.

    CAS  PubMed  Google Scholar 

  8. Excitotoxicity: bridge to various triggers in neurodegenerative disorders. Eur. J. Pharmacol. 2012;698(1-3):6-18.

  9. Krystal JH, D’Souza DC, Mathalon D, Perry E, Belger A, Hoffman R. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berl). 2003;169(3-4):215-233.

    Article  CAS  Google Scholar 

  10. Liu Y, Wong TP, Aarts M, Rooyakkers A, Liu L, Lai TW, Wu DC, Lu J, Tymianski M, Craig AM, Wang YT. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J. Neurosci. 2007;27(11):2846-2857.

    Article  CAS  PubMed  Google Scholar 

  11. Moghaddam B, Jackson ME. Glutamatergic animal models of schizophrenia. Ann. NY Acad. Sci. 2003;1003:131-137.

    Article  CAS  PubMed  Google Scholar 

  12. O’Neill MJ, Bleakman D, Zimmerman DM, Nisenbaum ES. AMPA receptor potentiators for the treatment of CNS disorders. Curr. Drug Targets CNS Neurol. Disord. 2004;3(3):181-194.

    Article  PubMed  Google Scholar 

  13. Sundaram RS, Gowtham L, Bhabani SN. The role of excitatory neurotransmitter glutamate in brain physiology and pathology. Asian J. Pharm. Clin. Res. 2012;5(2):1-7.

    Google Scholar 

  14. Yurkewicz L, Weaver J, Bullock MR, Marshall LF. The effect of the selective NMDA receptor antagonist traxoprodil in the treatment of traumatic brain injury. J. Neurotrauma. 2005;22(12):1428-1443.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Design Technological Institute of Digital Techniques, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia

    S. O. Vechkapova, T. A. Zapara, A. L. Proskura & A. S. Ratushnyak

  2. N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Division of the Russian Academy of Sciences, Novosibirsk, Russia

    E. A. Morozova, E. E. Schul’ts & T. G. Tolstikova

Authors
  1. S. O. Vechkapova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. A. Zapara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. A. Morozova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. L. Proskura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. E. Schul’ts
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T. G. Tolstikova
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A. S. Ratushnyak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. O. Vechkapova.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 161, No. 6, pp. 736-739, June, 2016

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vechkapova, S.O., Zapara, T.A., Morozova, E.A. et al. Amide of Lambertian Acid Suppresses Hyperactivation of Inotropic Glutamate Receptors, but not Synaptic Potentiation in Hippocampal Sections. Bull Exp Biol Med 161, 782–785 (2016). https://doi.org/10.1007/s10517-016-3509-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-016-3509-9

Key Words

Search

Navigation